Abstract

Nitric oxide (NO) is a unique mediator which may promote or suppress inflammation. In this study, we examine the effect of exogenous NO on nuclear translocation of nuclear factor-kappa B (NF-κB) in quiescent human umbilical vein endothelial cells (HUVECs) subsequently activated by tumor necrosis factor-α (TNF-α), and in HUVECs previously activated by TNF-α, a model of vascular inflammation. Quiescent and activated HUVECs are exposed to exogenous NO donors of varying half-lives and the degree of NF-κB translocation into the nucleus determined by unique application of immunofluorescence image analysis in whole cells and correlative biochemical analysis of activated NF-κB proteins in the nucleus. NO donors with shorter half-lives are more effective in blocking the activation and translocation of NF-κB, when added to quiescent HUVECs prior to cellular activation by TNF-α. However, in previously activated HUVECs where NF-κB had relocated into the cytoplasm, addition of short half-life NO donors, but not TNF-α, induced re-translocation of NF-κB back into the nucleus sustaining the inflamed cell phenotype. These data suggest that NO as an inhibitor or activator of NF-κB may depend on the state of activation of vascular endothelial cells in which it contacts. Additionally, in activated cells, NO may modulate expression of NF-κB-dependent gene products, when cytokines are ineffective.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.